Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition

• Amy Allen ,

  Contributed equally to this work with: Amy Allen, Alice Can Ran Qin, Nitya Raj

  Roles Investigation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0002-0554-2736

  ⨯
• Alice Can Ran Qin ,

  Contributed equally to this work with: Amy Allen, Alice Can Ran Qin, Nitya Raj

  Roles Investigation

  Affiliation Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Nitya Raj ,

  Contributed equally to this work with: Amy Allen, Alice Can Ran Qin, Nitya Raj

  Roles Data curation, Investigation, Writing – original draft, Writing – review & editing

  Affiliation Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Jiawan Wang,

  Roles Writing – review & editing

  Affiliation Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Sharmeen Uddin,

  Roles Investigation

  Affiliation Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Zhan Yao,

  Roles Conceptualization, Methodology, Resources

  Affiliation Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Laura Tang,

  Roles Investigation

  Affiliation Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Paul A. Meyers,

  Roles Investigation

  Affiliation Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Barry S. Taylor,

  Roles Formal analysis, Funding acquisition

  Affiliation Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Michael F. Berger,

  Roles Methodology, Resources

  Affiliations Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America, Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Rona Yaeger,

  Roles Writing – review & editing

  Affiliation Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Diane Reidy-Lagunes,

  Roles Conceptualization, Funding acquisition, Investigation, Supervision, Writing – review & editing

  Affiliation Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Christine A. Pratilas

  Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: cpratil1@jhmi.edu

  Affiliation Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯